Overview
- 6 inspections across 6 sites are on record.
- 0 Form 483 observations are attributed to this investigator.
- Most recent recorded activity is 2026-05-20.
At a glance
Inspections
6
Sites
6
Observations
0
Career since
Mar 2024
Recent inspections
Most recent inspections in the published record.
| Site | Date | Category | Form 483 |
|---|---|---|---|
| Shanghai Henlius Biopharmaceuticals Co., Ltd. | 20 May 2026 | Human Drugs | On file |
| Regeneron Pharmaceuticals, Inc. | 16 Jan 2026 | Human Drugs | On file |
| DR. REDDY'S LABORATORIES LTD | 12 Sep 2025 | Human Drugs | On file |
| Bio-Thera Solutions, Ltd. | 17 Jan 2025 | Human Drugs | On file |
| Suzhou Suncadia Biopharmaceuticals Co., Ltd | 6 Jan 2025 | Human Drugs | On file |
Sites inspected
Shanghai Henlius Biopharmaceuticals Co., Ltd.Shanghai, China1 insp.
Regeneron Pharmaceuticals, Inc.East Greenbush, United States1 insp.
DR. REDDY'S LABORATORIES LTDBachupally, India1 insp.
Bio-Thera Solutions, Ltd.Guangzhou, China1 insp.
Suzhou Suncadia Biopharmaceuticals Co., LtdSuzhou, China1 insp.
Co-investigators
Investigators who share inspections with this person.
Yiwei Li2 shared
Jeanne M Fringer2 shared
Xiaoshi Wang1 shared
Hamet M Toure1 shared
Jie He1 shared
Cassandra L Abellard1 shared
Baikuntha Aryal1 shared
Madushini N Dharmasena1 shared
Thuy T Nguyen1 shared
Michael Shanks1 shared
Full investigator report
Get the verbatim findings behind Jiangsong Jiang's inspection record
Source 483 PDFs, verbatim observations, and how each site responded, so your team knows what they cite before they arrive.
- New inspections and Form 483s, mapped to the CFR citation
- Warning letter outcomes, and the citation patterns they repeat
- Their co-investigators, so no surprises about who shows up on site